Bayer wins Norway cancer firm Algeta with raised $2.9 bln offer
OSLO Dec 19 (Reuters) - Bayer has raised its offer for Norway's Algeta, its partner for a new prostate cancer treatment, to 362 Norwegian crowns per share, valuing Algeta's equity at 2.1 billion euros ($2.9 billion).
Bayer in late November offered to pay 336 Norwegian crowns per Algeta share. ($1 = 0.7266 euros) (Reporting by Gwladys Fouche, editing by Terje Solsvik)
- After Nevada ranch stand-off, emboldened militias ask: where next?
- South Korea investigates capsized ferry crew as rescue hampered by tides |
- Retailer Michaels Stores confirms payment card data breach
- Nobel winner Garcia Marquez, master of magical realism, dies at 87 |
- All 338 Korean students, teachers rescued from sinking ferry - school official